{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:25:18Z","timestamp":1787102718199,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04160-w","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:26:00Z","timestamp":1781281560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing tDCS cognitive outcomes in schizophrenia: the role of dopaminergic tone and antipsychotic load"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-9762","authenticated-orcid":false,"given":"Lorena","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-1744","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Romero-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberth Patricio","family":"Mu\u00f1oz-Gualan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cardona-Bejarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7448-804X","authenticated-orcid":false,"given":"Daniel","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Ripoll Ay\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mole\u00f3n-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mart\u00edn-Bejarano Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-7249","authenticated-orcid":false,"given":"Roberto","family":"Rodriguez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"4160_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00406-022-01416-6","volume":"272","author":"Y Gebreegziabhere","year":"2022","unstructured":"Gebreegziabhere Y, Habatmu K, Mihretu A, Cella M, Alem A. Cognitive impairment in people with schizophrenia: an umbrella review. Eur Arch Psychiatry Clin Neurosci. 2022;272:1139\u201355. https:\/\/doi.org\/10.1007\/s00406-022-01416-6.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4160_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-pharmtox-051921-093250","volume":"63","author":"DC Javitt","year":"2023","unstructured":"Javitt DC. Cognitive impairment associated with schizophrenia: from pathophysiology to treatment. Annu Rev Pharmacol Toxicol. 2023;63:119\u201341. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051921-093250.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4160_CR3","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318. https:\/\/doi.org\/10.1038\/s41380-023-01949-9.","journal-title":"Mol Psychiatry"},{"key":"4160_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/ijnp\/pyaa051","volume":"24","author":"F Fregni","year":"2021","unstructured":"Fregni F, El-Hagrassy MM, Pacheco-Barrios K, Carvalho S, Leite J, Simis M, et al. Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders. Int J Neuropsychopharmacol. 2021;24:256\u2013313. https:\/\/doi.org\/10.1093\/ijnp\/pyaa051.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4160_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05112-0","volume":"23","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xia X, Zhao X, Yang R, Wu Y, Liu J, et al. Efficacy and safety of transcranial direct current stimulation (tDCS) on cognitive function in chronic schizophrenia with tardive dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial. BMC Psychiatry. 2023;23:623. https:\/\/doi.org\/10.1186\/s12888-023-05112-0.","journal-title":"BMC Psychiatry"},{"key":"4160_CR6","doi-asserted-by":"publisher","first-page":"116308","DOI":"10.1016\/j.psychres.2024.116308","volume":"344","author":"L Garc\u00eda-Fern\u00e1ndez","year":"2025","unstructured":"Garc\u00eda-Fern\u00e1ndez L, Romero-Ferreiro V, Padilla S, Wynn R, P\u00e9rez-G\u00e1lvez B, \u00c1lvarez-Mon M\u00c1, et al. Transcranial direct current stimulation (tDCS) enhances cognitive function in schizophrenia: a randomized double-blind sham-controlled trial. Psychiatry Res. 2025;344:116308. https:\/\/doi.org\/10.1016\/j.psychres.2024.116308.","journal-title":"Psychiatry Res"},{"key":"4160_CR7","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.scog.2024.100335","volume":"39","author":"SR Safwi","year":"2025","unstructured":"Safwi SR, Rizvi A, Usmani MA, Husain K, Brar K, Yadava D. Transcranial direct current stimulation and its effect on cognitive symptoms of schizophrenia: an updated review. Schizophr Res Cogn. 2025;39:100335. https:\/\/doi.org\/10.1016\/j.scog.2024.100335.","journal-title":"Schizophr Res Cogn"},{"key":"4160_CR8","doi-asserted-by":"publisher","first-page":"e2412616","DOI":"10.1001\/jamanetworkopen.2024.12616","volume":"7","author":"M Sab\u00e9","year":"2024","unstructured":"Sab\u00e9 M, Hyde J, Cramer C, Eberhard A, Crippa A, Brunoni AR, et al. Transcranial magnetic stimulation and transcranial direct current stimulation across mental disorders. JAMA Netw Open. 2024;7:e2412616. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.12616.","journal-title":"JAMA Netw Open"},{"key":"4160_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119501","volume":"260","author":"C Evans","year":"2022","unstructured":"Evans C, Zich C, Lee JSA, Ward N, Bestmann S. Inter-individual variability in current direction for common tDCS montages. Neuroimage. 2022;260:119501. https:\/\/doi.org\/10.1016\/j.neuroimage.2022.119501.","journal-title":"Neuroimage"},{"key":"4160_CR10","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1113\/jphysiol.2010.190314","volume":"588","author":"MC Ridding","year":"2010","unstructured":"Ridding MC, Ziemann U. Determinants of the induction of cortical plasticity by non-invasive brain stimulation in healthy subjects. J Physiol. 2010;588:2291\u2013304. https:\/\/doi.org\/10.1113\/jphysiol.2010.190314.","journal-title":"J Physiol"},{"key":"4160_CR11","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1038\/s41380-022-01572-0","volume":"27","author":"M Wada","year":"2022","unstructured":"Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, et al. Dopaminergic dysfunction and excitatory\/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment. Mol Psychiatry. 2022;27:2950\u201367. https:\/\/doi.org\/10.1038\/s41380-022-01572-0.","journal-title":"Mol Psychiatry"},{"key":"4160_CR12","doi-asserted-by":"publisher","first-page":"735.","DOI":"10.3390\/cells10040735","volume":"10","author":"L Speranza","year":"2021","unstructured":"Speranza L, di Porzio U, Viggiano D, de Donato A, Volpicelli F. Dopamine: the neuromodulator of long-term synaptic plasticity, reward and movement control. Cells. 2021;10:735. https:\/\/doi.org\/10.3390\/cells10040735.","journal-title":"Cells"},{"key":"4160_CR13","doi-asserted-by":"publisher","first-page":"105317","DOI":"10.1016\/j.neubiorev.2023.105317","volume":"152","author":"LE Savidge","year":"2023","unstructured":"Savidge LE, Bales KL. Possible effects of pair bonds on general cognition: evidence from shared roles of dopamine. Neurosci Biobehav Rev. 2023;152:105317. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105317.","journal-title":"Neurosci Biobehav Rev"},{"key":"4160_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biopsych.2015.12.028","volume":"81","author":"AFT Arnsten","year":"2017","unstructured":"Arnsten AFT, Girgis RR, Gray DL, Mailman RB. Novel dopamine therapeutics for cognitive deficits in schizophrenia. Biol Psychiatry. 2017;81:67\u201377. https:\/\/doi.org\/10.1016\/j.biopsych.2015.12.028.","journal-title":"Biol Psychiatry"},{"key":"4160_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016;17:524\u201332. https:\/\/doi.org\/10.1038\/nrn.2016.57.","journal-title":"Nat Rev Neurosci"},{"key":"4160_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brs.2019.08.016","volume":"13","author":"C Borwick","year":"2020","unstructured":"Borwick C, Lal R, Lim LW, Stagg CJ, Aquili L. Dopamine depletion effects on cognitive flexibility as modulated by tDCS of the dlPFC. Brain Stimul. 2020;13:105\u20138. https:\/\/doi.org\/10.1016\/j.brs.2019.08.016.","journal-title":"Brain Stimul"},{"key":"4160_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.113091","volume":"402","author":"MJ Imburgio","year":"2021","unstructured":"Imburgio MJ, Ballard HK, Cornwall AC, Worthy DA, Bernard JA, Orr JM, et al. Preliminary effects of prefrontal tDCS on dopamine-mediated behavior and psychophysiology. Behav Brain Res. 2021;402:113091. https:\/\/doi.org\/10.1016\/j.bbr.2020.113091.","journal-title":"Behav Brain Res"},{"key":"4160_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23694-9","volume":"12","author":"U Braun","year":"2021","unstructured":"Braun U, Harneit A, Pergola G, Menara T, Sch\u00e4fer A, Betzel RF, et al. Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat Commun. 2021;12:3478. https:\/\/doi.org\/10.1038\/s41467-021-23694-9.","journal-title":"Nat Commun"},{"key":"4160_CR19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/s41593-023-01390-9","volume":"26","author":"S Yun","year":"2023","unstructured":"Yun S, Yang B, Anair JD, Martin MM, Fleps SW, Pamukcu A, et al. Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons. Nat Neurosci. 2023;26:1417\u201328. https:\/\/doi.org\/10.1038\/s41593-023-01390-9.","journal-title":"Nat Neurosci"},{"key":"4160_CR20","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1017\/S1092852924002244","volume":"30","author":"JM Meyer","year":"2025","unstructured":"Meyer JM. How antipsychotics work in schizophrenia: a primer on mechanisms. CNS Spectr. 2025;30:e6. https:\/\/doi.org\/10.1017\/S1092852924002244.","journal-title":"CNS Spectr"},{"key":"4160_CR21","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1523\/JNEUROSCI.3655-13.2014","volume":"34","author":"S Fresnoza","year":"2014","unstructured":"Fresnoza S, Paulus W, Nitsche MA, Kuo M-F. Nonlinear dose-dependent impact of D1 receptor activation on motor cortex plasticity in humans. J Neurosci. 2014;34:2744\u201353. https:\/\/doi.org\/10.1523\/JNEUROSCI.3655-13.2014.","journal-title":"J Neurosci"},{"key":"4160_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/13651501.2022.2151473","volume":"27","author":"D Taylor","year":"2023","unstructured":"Taylor D, Chithiramohan R, Grewal J, Gupta A, Hansen L, Reynolds GP, et al. Dopamine partial agonists: a discrete class of antipsychotics. Int J Psychiatry Clin Pract. 2023;27:272\u201384. https:\/\/doi.org\/10.1080\/13651501.2022.2151473.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"4160_CR23","doi-asserted-by":"publisher","first-page":"113955","DOI":"10.1016\/j.expneurol.2021.113955","volume":"349","author":"M Bajbouj","year":"2022","unstructured":"Bajbouj M. Transformation towards precision psychiatry. Exp Neurol. 2022;349:113955. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113955.","journal-title":"Exp Neurol"},{"key":"4160_CR24","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1017\/S0033291724000370","volume":"54","author":"E van Dellen","year":"2024","unstructured":"van Dellen E. Precision psychiatry: predicting predictability. Psychol Med. 2024;54:1500\u20139. https:\/\/doi.org\/10.1017\/S0033291724000370.","journal-title":"Psychol Med"},{"key":"4160_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.psychres.2015.11.042","volume":"235","author":"SM Agarwal","year":"2016","unstructured":"Agarwal SM, Bose A, Shivakumar V, Narayanaswamy JC, Chhabra H, Kalmady SV, et al. Impact of antipsychotic medication on transcranial direct current stimulation (tDCS) effects in schizophrenia patients. Psychiatry Res. 2016;235:97\u2013103. https:\/\/doi.org\/10.1016\/j.psychres.2015.11.042.","journal-title":"Psychiatry Res"},{"key":"4160_CR26","unstructured":"American Psychiatric Association. Schizophrenia spectrum and other psychotic disorders. In: Diagnostic and statistical manual of mental disorders 5th ed, text revision (DSM-5-TR). Arlington, VA: American Psychiatric Association Publishing; 2022. pp. 87\u2013122."},{"key":"4160_CR27","first-page":"37","volume-title":"Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV)","author":"MB First","year":"2016","unstructured":"First MB, Williams JBW, Karg RS, Spitzer RL Differential diagnosis of psychotic disorders. In: Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). Arlington, VA: American Psychiatric Association Publishing; 2016. pp. 37\u201344."},{"key":"4160_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376. https:\/\/doi.org\/10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"key":"4160_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","volume":"165","author":"KH Nuechterlein","year":"2008","unstructured":"Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203\u201313. https:\/\/doi.org\/10.1176\/appi.ajp.2007.07010042.","journal-title":"Am J Psychiatry"},{"key":"4160_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.schres.2011.11.026","volume":"134","author":"R Rodr\u00edguez-Jim\u00e9nez","year":"2012","unstructured":"Rodr\u00edguez-Jim\u00e9nez R, Bagney A, Garc\u00eda-Navarro C, Aparicio AI, L\u00f3pez-Ant\u00f3n R, Moreno-Ortega M, et al. The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain. Schizophr Res. 2012;134:279\u201384. https:\/\/doi.org\/10.1016\/j.schres.2011.11.026.","journal-title":"Schizophr Res"},{"key":"4160_CR31","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull. 2016;42:S90\u2013S94. https:\/\/doi.org\/10.1093\/schbul\/sbv167.","journal-title":"Schizophr Bull"},{"key":"4160_CR32","doi-asserted-by":"publisher","first-page":"e300546","DOI":"10.1136\/bmjment-2022-300546","volume":"26","author":"C-L Yu","year":"2023","unstructured":"Yu C-L, Carvalho AF, Thompson T, Tsai T-C, Tseng P-T, Hsu C-W, et al. Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia. BMJ Ment Health. 2023;26:e300546. https:\/\/doi.org\/10.1136\/bmjment-2022-300546.","journal-title":"BMJ Ment Health"},{"key":"4160_CR33","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","volume":"69","author":"R Cools","year":"2011","unstructured":"Cools R, D\u2019Esposito M. Inverted-U\u2013shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 2011;69:e113\u2013e125. https:\/\/doi.org\/10.1016\/j.biopsych.2011.03.028.","journal-title":"Biol Psychiatry"},{"key":"4160_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0165-0173(99)00045-4","volume":"31","author":"P Goldman-Rakic","year":"2000","unstructured":"Goldman-Rakic P. D1 receptors in prefrontal cells and circuits. Brain Res Rev. 2000;31:295\u2013301. https:\/\/doi.org\/10.1016\/S0165-0173(99)00045-4.","journal-title":"Brain Res Rev"},{"key":"4160_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/cercor\/bhm172","volume":"18","author":"Y Goto","year":"2008","unstructured":"Goto Y, Grace AA. Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior. Cereb Cortex. 2008;18:1407\u201314. https:\/\/doi.org\/10.1093\/cercor\/bhm172.","journal-title":"Cereb Cortex"},{"key":"4160_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.05.006","volume":"74","author":"JK Seamans","year":"2004","unstructured":"Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004;74:1\u201358. https:\/\/doi.org\/10.1016\/j.pneurobio.2004.05.006.","journal-title":"Prog Neurobiol"},{"key":"4160_CR37","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/npp.2011.100","volume":"36","author":"K Monte-Silva","year":"2011","unstructured":"Monte-Silva K, Ruge D, Teo JT, Paulus W, Rothwell JC, Nitsche MA, et al. D2 receptor block abolishes theta burst stimulation-induced neuroplasticity in the human motor cortex. Neuropsychopharmacology. 2011;36:2097\u2013102. https:\/\/doi.org\/10.1038\/npp.2011.100.","journal-title":"Neuropsychopharmacology"},{"key":"4160_CR38","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1093\/cercor\/bhac028","volume":"32","author":"E Ghanavati","year":"2022","unstructured":"Ghanavati E, Salehinejad MA, de Melo L, Nitsche MA, Kuo M-F. NMDA receptor\u2013related mechanisms of dopaminergic modulation of tDCS-induced neuroplasticity. Cereb Cortex. 2022;32:5478\u201388. https:\/\/doi.org\/10.1093\/cercor\/bhac028.","journal-title":"Cereb Cortex"},{"key":"4160_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.neuroimage.2013.05.117","volume":"85","author":"M-F Kuo","year":"2014","unstructured":"Kuo M-F, Paulus W, Nitsche MA. Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases. Neuroimage. 2014;85:948\u201360. https:\/\/doi.org\/10.1016\/j.neuroimage.2013.05.117.","journal-title":"Neuroimage"},{"key":"4160_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.brs.2012.04.011","volume":"6","author":"K Monte-Silva","year":"2013","unstructured":"Monte-Silva K, Kuo M-F, Hessenthaler S, Fresnoza S, Liebetanz D, Paulus W, et al. Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation. Brain Stimul. 2013;6:424\u201332. https:\/\/doi.org\/10.1016\/j.brs.2012.04.011.","journal-title":"Brain Stimul"},{"key":"4160_CR41","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1460-9568.2006.04676.x","volume":"23","author":"MA Nitsche","year":"2006","unstructured":"Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F, et al. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Eur J Neurosci. 2006;23:1651\u20137. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04676.x.","journal-title":"Eur J Neurosci"},{"key":"4160_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HRP.0000000000000411","volume":"32","author":"L Garc\u00eda-Fern\u00e1ndez","year":"2024","unstructured":"Garc\u00eda-Fern\u00e1ndez L, Romero-Ferreiro V, Pe\u00f1uelas-Calvo I, \u00c1lvarez-Mon MA, Scala M, Romero-Ferreiro C, et al. Cariprazine and cognition in patients with schizophrenia and bipolar disorder: a systematic review. Harv Rev Psychiatry. 2024;32:207\u201317. https:\/\/doi.org\/10.1097\/HRP.0000000000000411.","journal-title":"Harv Rev Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04160-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:47:47Z","timestamp":1787100467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04160-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4160"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04160-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RRJ has been a consultant for, spoken in activities of, or received grants from: Instituto de Salud Carlos III, Fondo de Investigaci\u00f3n Sanitaria (FIS), Centro de Investigaci \u0301on Biom\u00e9dica en Red de Salud Mental (CIBERSAM), Madrid Regional Government (S2010\/BMD-2422 AGES; S2017\/BMD-3740), JanssenCilag, Lundbeck, Otsuka, Pfizer, Ferrer, Juste, Takeda, Exeltis, Casen-Recordati,Angelini, Rovi. All other authors have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"418"}}